Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
1.
Proc Natl Acad Sci U S A ; 106(31): 13088-93, 2009 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-19622729

RESUMEN

We have shown that somatostatin released from activated capsaicin-sensitive nociceptive nerve endings during inflammatory processes elicits systemic anti-inflammatory and analgesic effects. With the help of somatostatin receptor subtype 4 gene-deleted mice (sst(4)(-/-)), we provide here several lines of evidence that this receptor has a protective role in a variety of inflammatory disease models; several symptoms are more severe in the sst(4) knockout animals than in their wild-type counterparts. Acute carrageenan-induced paw edema and mechanical hyperalgesia, inflammatory pain in the early phase of adjuvant-evoked chronic arthritis, and oxazolone-induced delayed-type hypersensitivity reaction in the skin are much greater in mice lacking the sst(4) receptor. Airway inflammation and consequent bronchial hyperreactivity elicited by intranasal lipopolysaccharide administration are also markedly enhanced in sst(4) knockouts, including increased perivascular/peribronchial edema, neutrophil/macrophage infiltration, mucus-producing goblet cell hyperplasia, myeloperoxidase activity, and IL-1beta, TNF-alpha, and IFN-gamma expression in the inflamed lung. It is concluded that during these inflammatory conditions the released somatostatin has pronounced counterregulatory effects through sst(4) receptor activation. Thus, this receptor is a promising novel target for developing anti-inflammatory, analgesic, and anti-asthmatic drugs.


Asunto(s)
Hiperreactividad Bronquial/etiología , Hiperalgesia/etiología , Inflamación/etiología , Receptores de Somatostatina/fisiología , Animales , Hiperreactividad Bronquial/prevención & control , Dermatitis Alérgica por Contacto/etiología , Femenino , Hiperalgesia/prevención & control , Inflamación/prevención & control , Lipopolisacáridos/toxicidad , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Oxazolona/toxicidad , Receptores de Somatostatina/deficiencia , Receptores de Somatostatina/genética
2.
Neuropharmacology ; 178: 108198, 2020 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-32739276

RESUMEN

We provided strong proof of concept evidence that somatostatin mediates potent analgesic and anti-inflammatory actions via its receptor subtype 4 (sst4) located both at the periphery and the central nervous system. Therefore, sst4 agonists are promising novel drug candidates for neuropathic pain and neurogenic inflammation, but rational drug design was not possible due to the lack of knowledge about its 3-dimensional structure. We modeled the sst4 receptor structure, described its agonist binding properties, and characterized the binding of our novel small molecule sst4 agonists (4-phenetylamino-7H-pyrrolo[2,3-d]pyrimidine derivatives) using an in silico platform. In addition to the in silico binding data, somatostatin displacement by Compound 1 was demonstrated in the competitive binding assay on sst4-expressing cells. In vivo effects were investigated in rat models of neurogenic inflammation and chronic traumatic neuropathic pain. We defined high- and low-affinity binding pockets of sst4 for our ligands, binding of the highest affinity compounds were similar to that of the reference ligand J-2156. We showed potent G-protein activation with the highest potency of 10 nM EC50 value and highest efficacy of 342%. Oral administration of 100 µg/kg of 5 compounds significantly inhibited acute neurogenic plasma protein extravasation in the paw skin by 40-60%, one candidate abolished and 3 others diminished sciatic nerve-ligation induced neuropathic hyperalgesia by 28-62%. The in silico predictions on sst4-ligands were tested in biological systems. Low oral dose of our novel agonists inhibit neurogenic inflammation and neuropathic pain, which opens promising drug developmental perspectives for these unmet medical need conditions.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios/farmacología , Receptores de Somatostatina/agonistas , Secuencia de Aminoácidos , Analgésicos/química , Analgésicos/metabolismo , Animales , Antiinflamatorios/química , Antiinflamatorios/metabolismo , Células CHO , Cricetinae , Cricetulus , Relación Dosis-Respuesta a Droga , Femenino , Células HEK293 , Humanos , Masculino , Dimensión del Dolor/efectos de los fármacos , Dimensión del Dolor/métodos , Unión Proteica/fisiología , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Ratas , Ratas Wistar , Receptores de Somatostatina/química , Receptores de Somatostatina/genética , Receptores de Somatostatina/metabolismo
3.
Neurosci Lett ; 451(3): 204-7, 2009 Feb 27.
Artículo en Inglés | MEDLINE | ID: mdl-19159661

RESUMEN

The inflammatory actions of xylene, an aromatic irritant and sensitizing agent, were described to be predominantly neurogenic in the rat, but the mechanism and the role of the Transient Receptor Potential Vanilloid 1 (TRPV1) capsaicin receptor localized on a subpopulation of sensory nerves has not been elucidated. This paper characterizes the involvement of capsaicin-sensitive afferents and the TRPV1 receptor in nociceptive and acute inflammatory effects of xylene in the mouse. Topical application of xylene on the paw induced a short, intensive nocifensive behaviour characterized by paw liftings and shakings, which was more intensive in Balb/c than in C57Bl/6 mice. Genetic deletion of the TRPV1 receptor as well as destroying capsaicin-sensitive nerve terminals with resiniferatoxin (RTX) pretreatment markedly reduced, but did not abolish nocifensive behaviours. In respect to the xylene-induced plasma protein extravasation detected by Evans blue leakage, significant difference was neither observed between the Balb/c and C57Bl/6 strains, nor the ear and the dorsal paw skin. These inflammatory responses were diminished in the RTX pretreated group, but not in the TRPV1 gene-deleted one. Injection of the antioxidant N-acetylcysteine 15min prior to xylene smearing significantly reduced plasma protein extravasation at both sites. These results demonstrate that xylene-induced acute nocifensive behaviour is mediated by capsaicin-sensitive afferents via TRPV1 receptor activation in mice. Neurogenic inflammatory components play an important role in xylene-induced plasma protein extravasation, but independently of the TRPV1 ion channel. Reactive oxygen or carbonyl species participate in this process presumably via stimulation of the TRPA1 channel.


Asunto(s)
Inflamación Neurogénica/fisiopatología , Nociceptores/fisiología , Dolor/fisiopatología , Células Receptoras Sensoriales/fisiología , Canales Catiónicos TRPV/metabolismo , Vías Aferentes/efectos de los fármacos , Vías Aferentes/fisiología , Animales , Conducta Animal/efectos de los fármacos , Conducta Animal/fisiología , Capsaicina/farmacología , Modelos Animales de Enfermedad , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , Proteínas del Tejido Nervioso/metabolismo , Inflamación Neurogénica/inducido químicamente , Inflamación Neurogénica/metabolismo , Nociceptores/efectos de los fármacos , Dolor/inducido químicamente , Dolor/metabolismo , Dimensión del Dolor/efectos de los fármacos , Umbral del Dolor/efectos de los fármacos , Umbral del Dolor/fisiología , Terminales Presinápticos/efectos de los fármacos , Terminales Presinápticos/patología , Células Receptoras Sensoriales/efectos de los fármacos , Fármacos del Sistema Sensorial/farmacología , Canales Catiónicos TRPV/efectos de los fármacos , Xilenos/farmacología
4.
Eur J Pharmacol ; 578(2-3): 313-22, 2008 Jan 14.
Artículo en Inglés | MEDLINE | ID: mdl-17961545

RESUMEN

Somatostatin released from activated capsaicin-sensitive afferents of the lung inhibits inflammation and related bronchial hyperreactivity presumably via somatostatin 4 receptors (sst(4)). The aim of this study was to examine the effects of TT-232, a heptapeptide sst(4)/sst(1) receptor agonist and J-2156, a high affinity sst(4) receptor-selective peptidomimetic agonist in airway inflammation models. Acute pneumonitis was evoked by intranasal lipopolysaccharide 24 h before measurement. Chronic inflammation was induced by ovalbumin inhalation on days 28, 29 and 30 after i.p. sensitization on days 1 and 14. Semiquantitative histopathological scoring was based on perivascular/peribronchial oedema, neutrophil/macrophage infiltration, goblet cell hyperplasia in the acute model and eosinophil infiltration, mucosal oedema, mucus production and epithelial cell damage in chronic inflammation. Myeloperoxidase activity of the lung was measured spectrophotometrically to quantify granulocyte accumulation and the broncoalveolar lavage fluid was analysed by flow cytometry. Carbachol-induced bronchoconstriction was assessed by unrestrained whole body plethysmography and its calculated indicator, enhanced pause (Penh) was determined. TT-232 and J-2156 induced similar inhibition on granulocyte recruitment and histopathological changes in both models, although macrophage infiltration in LPS-induced inflammation was unaltered by either compounds. Both agonists diminished inflammatory airway hyperresponsiveness. Since their single administration after the development of the inflammatory reactions also inhibited carbachol-induced bronchoconstriction, somatostatin sst(4) receptor activation on bronchial smooth muscle cells is likely to be involved in their anti-hyperreactivity effect. These results suggest that stable, somatostatin sst(4) receptor-selective agonists could be potential candidates for the development of a completely novel group of anti-inflammatory drugs for the treatment of airway inflammation and hyperresponsiveness.


Asunto(s)
Antiinflamatorios/farmacología , Asma/tratamiento farmacológico , Hiperreactividad Bronquial/prevención & control , Butanos/farmacología , Pulmón/efectos de los fármacos , Proteínas de la Membrana/agonistas , Naftalenos/farmacología , Péptidos Cíclicos/farmacología , Neumonía Bacteriana/tratamiento farmacológico , Receptores de Somatostatina/agonistas , Fármacos del Sistema Respiratorio/farmacología , Sulfonas/farmacología , Animales , Antiinflamatorios/uso terapéutico , Asma/inducido químicamente , Asma/metabolismo , Asma/patología , Asma/fisiopatología , Hiperreactividad Bronquial/metabolismo , Hiperreactividad Bronquial/patología , Hiperreactividad Bronquial/fisiopatología , Pruebas de Provocación Bronquial , Líquido del Lavado Bronquioalveolar/citología , Broncoconstrictores/administración & dosificación , Butanos/uso terapéutico , Carbacol/administración & dosificación , Células Cultivadas , Femenino , Interleucina-1beta/metabolismo , Lipopolisacáridos , Pulmón/metabolismo , Pulmón/patología , Pulmón/fisiopatología , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/metabolismo , Proteínas de la Membrana/metabolismo , Ratones , Ratones Endogámicos BALB C , Naftalenos/uso terapéutico , Ovalbúmina , Péptidos Cíclicos/uso terapéutico , Neumonía Bacteriana/inducido químicamente , Neumonía Bacteriana/metabolismo , Neumonía Bacteriana/patología , Neumonía Bacteriana/fisiopatología , Receptores de Somatostatina/metabolismo , Fármacos del Sistema Respiratorio/uso terapéutico , Somatostatina/análogos & derivados , Sulfonas/uso terapéutico , Acetato de Tetradecanoilforbol/farmacología , Factores de Tiempo
5.
Regul Pept ; 141(1-3): 44-54, 2007 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-17291600

RESUMEN

Substance P (SP) and calcitonin gene-related peptide (CGRP) released from capsaicin-sensitive afferents induce neurogenic inflammation via NK(1), NK(2) and CGRP1 receptor activation. This study examines the role of capsaicin-sensitive fibres and sensory neuropeptides in endotoxin-induced airway inflammation and consequent bronchial hyperreactivity with functional, morphological and biochemical techniques in mice. Carbachol-induced bronchoconstriction was measured with whole body plethysmography 24 h after intranasal lipopolysaccharide administration. SP and CGRP were determined with radioimmunoassay, myeloperoxidase activity with spectrophotometry, interleukin-1beta with ELISA and histopathological changes with semiquantitative scoring from lung samples. Treatments with resiniferatoxin for selective destruction of capsaicin-sensitive afferents, NK(1) antagonist SR 140333, NK(2) antagonist SR 48968, their combination, or CGRP1 receptor antagonist CGRP(8-37) were performed. Lipopolysaccharide significantly increased lung SP and CGRP concentrations, which was prevented by resiniferatoxin pretreatment. Resiniferatoxin-desensitization markedly enhanced inflammation, but decreased bronchoconstriction. CGRP(8-37) or combination of SR 140333 and SR 48968 diminished neutrophil accumulation, MPO levels and IL-1beta production, airway hyperresponsiveness was inhibited only by SR 48968. This is the first evidence that capsaicin-sensitive afferents exert a protective role in endotoxin-induced airway inflammation, but contribute to increased bronchoconstriction. Activation of CGRP1 receptors or NK(1)+NK(2) receptors participate in granulocyte accumulation, but NK(2) receptors play predominant role in enhanced airway resistance.


Asunto(s)
Hiperreactividad Bronquial/inmunología , Capsaicina/farmacología , Endotoxinas/toxicidad , Neuronas Aferentes/efectos de los fármacos , Neuropéptidos/metabolismo , Animales , Hiperreactividad Bronquial/inducido químicamente , Péptido Relacionado con Gen de Calcitonina/análisis , Ensayo de Inmunoadsorción Enzimática , Femenino , Histocitoquímica , Inflamación/inducido químicamente , Inflamación/patología , Interleucina-1beta/análisis , Pulmón/enzimología , Pulmón/patología , Ratones , Ratones Endogámicos C57BL , Peroxidasa/análisis , Radioinmunoensayo , Somatostatina/sangre , Espectrofotometría , Sustancia P/análisis
6.
Eur J Pharmacol ; 539(1-2): 71-5, 2006 Jun 06.
Artículo en Inglés | MEDLINE | ID: mdl-16697366

RESUMEN

Somatostatin released from capsaicin-sensitive afferents exerts systemic anti-nociceptive actions, presumably via somatostatin receptor subtype 4 (sst4). In the present study, the antinociceptive effects of a novel somatostatin sst4 receptor selective peptidomimetic compound, J-2156 (1-100 microg/kg i.p.), were examined. J-2156 inhibited nocifensive behaviour of mice in the second phase of the formalin test. Adjuvant-evoked chronic inflammatory mechanical allodynia was decreased in rats treated with J-2156 for 21 days. Sciatic nerve ligation-induced neuropathic mechanical hyperalgesia was inhibited by J-2156 on the seventh postoperative day. Results obtained using this highly selective agonist suggest that somatostatin sst4 receptors represent a promising target for new perspectives in analgesic therapy.


Asunto(s)
Analgésicos/farmacología , Butanos/farmacología , Proteínas de la Membrana/agonistas , Naftalenos/farmacología , Dolor/tratamiento farmacológico , Receptores de Somatostatina/agonistas , Sulfonas/farmacología , Enfermedad Aguda , Analgésicos/uso terapéutico , Animales , Butanos/uso terapéutico , Enfermedad Crónica , Hiperalgesia/tratamiento farmacológico , Masculino , Ratones , Ratones Endogámicos BALB C , Naftalenos/uso terapéutico , Dimensión del Dolor , Umbral del Dolor , Estimulación Física , Ratas , Ratas Wistar , Sulfonas/uso terapéutico , Tacto
7.
Pain ; 117(3): 368-376, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16150543

RESUMEN

Capsaicin-sensitive, TRPV1 (transient receptor potential vanilloid 1) receptor-expressing primary sensory neurons exert local and systemic efferent effects besides the classical afferent function. The TRPV1 receptor is considered a molecular integrator of various physico-chemical noxious stimuli. In the present study its role was analysed in acute nociceptive tests and chronic neuropathy models by comparison of wild-type (WT) and TRPV1 knockout (KO) mice. The formalin-induced acute nocifensive behaviour, carrageenan-evoked inflammatory mechanical hyperalgesia and partial sciatic nerve lesion-induced neuropathic mechanical hyperalgesia were not different in WT and KO animals. Acute nocifensive behaviour after intraplantar injection of phorbol 12-myristate 13-acetate, an activator of protein kinase C (PKC), was absent in TRPV1 KO animals showing that PKC activation elicits nociception exclusively through TRPV1 receptor sensitization/activation. Thermal hyperalgesia (drop of noxious heat threshold) and mechanical hyperalgesia induced by a mild heat injury (51 degrees C, 15s) was smaller in KO mice suggesting a pronociceptive role for TRPV1 receptor in burn injury. Chronic mechanical hyperalgesia evoked by streptozotocin-induced diabetic and cisplatin-evoked toxic polyneuropathy occurred earlier and were greater in the TRPV1 KO group. In both polyneuropathy models, at time points when maximal difference in mechanical hyperalgesia between the two groups was measured, plasma somatostatin concentrations determined by radioimmunoassay significantly increased in WT but not in TRPV1 KO mice. It is concluded that sensitization/activation of the TRPV1 receptor plays a pronociceptive role in certain models of acute tissue injury but under chronic polyneuropathic conditions it can initiate antinociceptive counter-regulatory mechanisms possibly mediated by somatostatin released from sensory neurons.


Asunto(s)
Nociceptores/efectos de los fármacos , Dolor/metabolismo , Canales Catiónicos TRPV/fisiología , Animales , Conducta Animal , Carragenina/efectos adversos , Cisplatino/efectos adversos , Modelos Animales de Enfermedad , Formaldehído/efectos adversos , Hiperalgesia/inducido químicamente , Hiperalgesia/fisiopatología , Ratones , Ratones Endogámicos NOD/fisiología , Ratones Noqueados , Dolor/inducido químicamente , Dolor/clasificación , Dimensión del Dolor/métodos , Somatostatina/sangre , Canales Catiónicos TRPV/deficiencia
8.
Eur J Pharmacol ; 517(1-2): 35-44, 2005 Jul 04.
Artículo en Inglés | MEDLINE | ID: mdl-15978575

RESUMEN

The TRPV1 capsaicin receptor is an integrator molecule on primary afferent neurones participating in inflammatory and nociceptive processes. The present paper characterizes the effects of JYL1421 (SC0030), a TRPV1 receptor antagonist, on capsaicin-evoked responses both in vitro and in vivo in the rat. JYL1421 concentration-dependently (0.1-2 microM) inhibited capsaicin-evoked substance P, calcitonin gene-related peptide and somatostatin release from isolated tracheae, while only 2 microM resulted in a significant inhibition of electrically induced neuropeptide release. Capsazepine (0.1-2 microM), as a reference compound, similarly diminished both capsaicin-evoked and electrically evoked peptide release. JYL1421 concentration-dependently decreased capsaicin-induced Ca(2+) accumulation in cultured trigeminal ganglion cells, while capsazepine was much less effective. In vivo 2 mg/kg i.p. JYL1421, but not capsazepine, inhibited capsaicin-induced hypothermia, eye wiping movements and reflex hypotension (a component of the pulmonary chemoreflex or Bezold-Jarisch reflex). Based on these data JYL1421 is a more selective and in most models also a more potent TRPV1 receptor antagonist than capsazepine, therefore it may promote the assessment of the (patho)physiological roles of the TRPV1 receptor.


Asunto(s)
Canales Iónicos/antagonistas & inhibidores , Sulfonamidas/farmacología , Tiourea/análogos & derivados , Animales , Presión Sanguínea/efectos de los fármacos , Temperatura Corporal/efectos de los fármacos , Péptido Relacionado con Gen de Calcitonina/metabolismo , Calcio/metabolismo , Capsaicina/análogos & derivados , Capsaicina/farmacología , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica , Técnicas In Vitro , Canales Iónicos/fisiología , Masculino , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neuropéptidos/metabolismo , Ratas , Ratas Wistar , Somatostatina/metabolismo , Sustancia P/metabolismo , Canales Catiónicos TRPV , Tiourea/farmacología , Tráquea/efectos de los fármacos , Tráquea/metabolismo
9.
Neurosci Lett ; 385(2): 137-42, 2005 Sep 09.
Artículo en Inglés | MEDLINE | ID: mdl-15950380

RESUMEN

The TRPV1 capsaicin receptor is a non-selective cation channel localized in the cell membrane of a subset of primary sensory neurons and functions as an integrator molecule in nociceptive/inflammatory processes. The present paper characterizes the effects of SB366791, a novel TRPV1 antagonist, on capsaicin-evoked responses both in vitro and in vivo using rat models. SB366791 (100 and 500 nM) significantly inhibited capsaicin-evoked release of the pro-inflammatory sensory neuropeptide substance P from isolated tracheae, while it did not influence electrically induced neuropeptide release. It also decreased capsaicin-induced Ca2+ influx in cultured trigeminal ganglion cells in a concentration-dependent manner (0.5-10 microM) with an IC50 of 651.9 nM. In vivo 500 microg/kg i.p. dose of SB366791 significantly inhibited capsaicin-induced hypothermia, wiping movements and vasodilatation in the knee joint, while 2 mg/kg capsazepine was ineffective, its effect lasted for 1h. However, neither antagonist was able to inhibit capsaicin-evoked hypothermia in Balb/c mice. Based on these data SB366791 is a more selective and in vivo also a more potent TRPV1 receptor antagonist than capsazepine in the rat therefore, it may promote the assessment of the therapeutic utility of TRPV1 channel blockers.


Asunto(s)
Anilidas/farmacología , Cinamatos/farmacología , Canales Iónicos/antagonistas & inhibidores , Neuronas Aferentes/efectos de los fármacos , Nociceptores/efectos de los fármacos , Dolor/metabolismo , Sistema Nervioso Periférico/efectos de los fármacos , Analgésicos/farmacología , Animales , Capsaicina/análogos & derivados , Capsaicina/antagonistas & inhibidores , Capsaicina/farmacología , Células Cultivadas , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas/fisiología , Hipotermia/tratamiento farmacológico , Hipotermia/fisiopatología , Hipotermia/prevención & control , Canales Iónicos/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Neuronas Aferentes/metabolismo , Nociceptores/metabolismo , Dolor/fisiopatología , Sistema Nervioso Periférico/metabolismo , Ratas , Ratas Wistar , Células Receptoras Sensoriales/efectos de los fármacos , Células Receptoras Sensoriales/metabolismo , Sustancia P/metabolismo , Canales Catiónicos TRPV , Ganglio del Trigémino/efectos de los fármacos , Ganglio del Trigémino/metabolismo
10.
Eur J Pharmacol ; 498(1-3): 103-9, 2004 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-15363982

RESUMEN

Somatostatin released from capsaicin-sensitive sensory nerves exerts systemic anti-inflammatory and antinociceptive actions. TT-232 is a stable, peripherally acting heptapeptide (D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2) somatostatin analogue with highest binding affinity for somatostatin sst4 receptors. It has been shown to inhibit acute and chronic inflammatory responses and sensory neuropeptide release from capsaicin-sensitive nociceptors. In the present study the antinociceptive effects of TT-232 were analysed using both acute and chronic models of nociception. Formalin-induced pain behaviour, noxious heat threshold and streptozotocin-induced diabetic neuropathic mechanical allodynia were examined in rats and phenylquinone-evoked abdominal constrictions were tested in mice. TT-232 (80 microg/kg i.p.) inhibited both early (0-5 min) and late phases (25-45 min) of formalin-induced nociception as revealed by determination of the composite pain score. The minimum effective dose to elevate the noxious heat threshold and diminish the heat threshold drop (heat allodynia) evoked by resiniferatoxin (0.05 nmol intraplantarly) was 20 and 10 microg/kg i.p., respectively, as measured by an increasing-temperature hot plate. TT-232 (10-200 microg/kg s.c.) significantly inhibited phenylquinone-evoked writhing movements in mice, but within this dose range no clear dose-response correlation was found. Five weeks after streptozotocin administration (50 mg/kg i.v.) the diabetes-induced decrease in the mechanonociceptive threshold was inhibited by 10-100 microg/kg i.p. TT-232. These findings show that TT-232 potently inhibits acute chemical somatic/visceral and thermal nociception and diminishes chronic mechanical allodynia associated with diabetic neuropathy, thereby it could open new perspectives in the treatment of various pain syndromes.


Asunto(s)
Analgésicos/farmacología , Diabetes Mellitus Experimental/complicaciones , Dolor/prevención & control , Péptidos Cíclicos/farmacología , Enfermedad Aguda , Animales , Conducta Animal/efectos de los fármacos , Benzoquinonas/toxicidad , Modelos Animales de Enfermedad , Diterpenos/toxicidad , Relación Dosis-Respuesta a Droga , Femenino , Formaldehído/toxicidad , Masculino , Ratones , Ratones Endogámicos BALB C , Dolor/inducido químicamente , Dolor/etiología , Dimensión del Dolor/métodos , Ratas , Ratas Wistar , Somatostatina/análogos & derivados
11.
Peptides ; 43: 105-12, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23499760

RESUMEN

Pituitary Adenylate-Cyclase Activating Polypeptide (PACAP) and Tac1 gene-encoded tachykinins (substance P: SP, neurokinin A: NKA) are expressed in capsaicin-sensitive nerves, but their role in nociception, inflammation and vasoregulation is unclear. Therefore, we investigated the function of these neuropeptides and the NK1 tachykinin receptor (from Tacr1 gene) in the partial sciatic nerve ligation-induced traumatic mononeuropathy model using gene deficient (PACAP(-/-), Tac1(-/-), and Tacr1(-/-)) mice. Mechanonociceptive threshold of the paw was measured with dynamic plantar aesthesiometry, motor coordination with Rota-Rod and cutaneous microcirculation with laser Doppler imaging. Neurogenic vasodilation was evoked by mustard oil stimulating sensory nerves. In wildtype mice 30-40% mechanical hyperalgesia developed one week after nerve ligation, which was not altered in Tac1(-/-) and Tacr1(-/-) mice, but was absent in PACAP(-/-) animals. Motor coordination of the PACAP(-/-) and Tac1(-/-) groups was significantly worse both before and after nerve ligation compared to their wildtypes, but it did not change in Tacr1(-/-) mice. Basal postoperative microcirculation on the plantar skin of PACAP(-/-) mice did not differ from the wildtypes, but was significantly lower in Tac1(-/-) and Tacr1(-/-) ones. In contrast, mustard oil-induced neurogenic vasodilation was significantly smaller in PACAP(-/-) mice, but not in Tacr1(-/-) and Tac1(-/-) animals. Both PACAP and SP/NKA, but not NK1 receptors participate in normal motor coordination. Tachykinins maintain basal cutaneous microcirculation. PACAP is a crucial mediator of neuropathic mechanical hyperalgesia and neurogenic vasodilation. Therefore identifying its target and developing selective, potent antagonists, might open promising new perspectives for the treatment of neuropathic pain and vascular complications.


Asunto(s)
Actividad Motora/fisiología , Neovascularización Fisiológica/fisiología , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/metabolismo , Células Receptoras Sensoriales/metabolismo , Taquicininas/metabolismo , Animales , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/deficiencia , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/genética , Receptores de Neuroquinina-1/genética , Receptores de Neuroquinina-1/metabolismo , Taquicininas/deficiencia , Taquicininas/genética
12.
J Mol Neurosci ; 46(1): 40-50, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21695504

RESUMEN

We showed that somatostatin (SST) exerts anti-inflammatory and anti-nociceptive effects through somatostatin receptor subtypes 4 and 1 (sst(4)/sst(1)). Since cortistatin (CST) is a structurally similar peptide, we aimed at comparing the sst(1)- and sst(4)-binding and activating abilities, as well as the effects of SST-14 and CST-14 on inflammatory and nociceptive processes. CST-14 concentration-dependently displaced radiolabeled SST-14 binding, induced similar sst(1) and sst(4)-activation with a less potency, and exerted significantly greater inhibitory effect on endotoxin-stimulated interleukin (IL)-1ß production of murine peritoneal macrophages. Capsaicin-induced calcitonin gene-related peptide release from peripheral sensory nerve terminals of isolated rat tracheae was significantly decreased by 2 µM CST and 100 nM SST, but concentration-response correlation was not found. Mustard oil-evoked acute neurogenic plasma protein extravasation in the rat hindpaw skin, carrageenan-induced mouse paw edema, mechanical hyperalgesia, and IL-1ß, tumor necrosis factor-α production, as well as mild heat injury-evoked thermal hyperalgesia were similarly attenuated by both peptides. In the latter case, i.pl. and i.p. injections exerted equal inhibitory actions. CST-14 and SST-14 similarly diminish both acute neurogenic and cellular inflammatory processes, as well as mechanical and heat hyperalgesia, in which their inhibitory effect on sensory nerve endings is likely to be involved. However, CST-14 exerts remarkably greater inhibition on cytokine production.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios/farmacología , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/patología , Inflamación Neurogénica/tratamiento farmacológico , Inflamación Neurogénica/patología , Neuropéptidos/farmacología , Péptidos Cíclicos/farmacología , Somatostatina/farmacología , Animales , Células CHO , Cricetinae , Modelos Animales de Enfermedad , Hiperalgesia/inducido químicamente , Masculino , Ratones , Ratones Endogámicos , Inflamación Neurogénica/inducido químicamente , Ratas , Ratas Wistar
13.
Peptides ; 32(7): 1439-46, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21605612

RESUMEN

The presence of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in capsaicin-sensitive peptidergic sensory nerves, inflammatory and immune cells suggest its involvement in inflammation. However, data on its role in different inflammatory processes are contradictory and there is little known about its functions in the airways. Therefore, our aim was to examine intranasal endotoxin-induced subacute airway inflammation in PACAP gene-deficient (PACAP⁻/⁻) and wild-type (PACAP⁺/⁺) mice. Airway responsiveness to inhaled carbachol was determined in unrestrained mice with whole body plethysmography 6 h and 24 h after LPS. Myeloperoxidase (MPO) activity referring to the number of accumulated neutrophils and macrophages was measured with spectrophotometry and interleukin-1ß (IL-1ß) concentration with ELISA from the lung homogenates. Histological evaluation and semiquantitative scoring were also performed. Bronchial responsiveness, as well as IL-1ß concentration and MPO activity markedly increased at both timepoints. Perivascular edema dominated the histological picture at 6 h, while remarkable peribronchial granulocyte accumulation, macrophage infiltration and goblet cell hyperplasia were seen at 24h. In PACAP⁻/⁻ mice, airway hyperreactivity was significantly higher 24 h after LPS and inflammatory histopathological changes were more severe at both timepoints. MPO increase was almost double in PACAP⁻/⁻ mice compared to the wild-types at 6 h. In contrast, there was no difference between the IL-1ß concentrations of the PACAP⁺/⁺ and PACAP⁻/⁻ mice. These results provide evidence for a protective role for PACAP in endotoxin-induced airway inflammation and hyperreactivity.


Asunto(s)
Bronquios/metabolismo , Hiperreactividad Bronquial/metabolismo , Inflamación/metabolismo , Lipopolisacáridos/efectos adversos , Pulmón/metabolismo , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa , Animales , Bronquios/efectos de los fármacos , Bronquios/inmunología , Bronquios/patología , Hiperreactividad Bronquial/inmunología , Hiperreactividad Bronquial/patología , Carbacol/farmacología , Agonistas Colinérgicos/farmacología , Ensayo de Inmunoadsorción Enzimática , Femenino , Granulocitos/inmunología , Granulocitos/metabolismo , Granulocitos/patología , Histocitoquímica , Inflamación/inmunología , Inflamación/patología , Interleucina-1beta/análisis , Interleucina-1beta/biosíntesis , Pulmón/efectos de los fármacos , Pulmón/inmunología , Pulmón/patología , Macrófagos/inmunología , Macrófagos/metabolismo , Macrófagos/patología , Ratones , Ratones Noqueados , Peroxidasa/análisis , Peroxidasa/metabolismo , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/deficiencia , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/genética , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/inmunología , Pletismografía Total
14.
J Mol Neurosci ; 42(1): 80-8, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20411352

RESUMEN

The aim of this study was to investigate the involvement of transient receptor potential vanilloid 1 (TRPV1) receptors in oral dextran sulfate sodium-induced (DSS) colitis using TRPV1 knockout mice and their wild-type C57BL/6 counterparts. DSS (2% or 5%) was administered orally ad libitum for 7 days; the controls received tap water. Animal weight, stool consistency, and blood content were scored every day to calculate the disease activity index (DAI). After sacrificing the mice on day 7, the colons were cut into three equal segments (proximal, intermediate, and distal) for histology, myeloperoxidase (MPO), and cytokine measurements. In the 2% DSS-treated group, the lack of TRPV1 receptors decreased the DAI. Each colon segment of wild-type animals showed more than two-fold increase of MPO activity and more severe histological changes compared to the knockouts. This difference was not observed in case of 5% DSS, when extremely severe inflammation occurred in both groups. IL-1beta production was not altered by the absence of TRPV1. In conclusion, activation of TRPV1 channels enhances the clinical symptoms, histopathological changes, and neutrophil accumulation induced by 2% DSS. Elucidating the modulator role of TRPV1 channels in inflammatory bowel diseases may contribute to the development of novel anti-inflammatory drugs for their therapy.


Asunto(s)
Colitis/inducido químicamente , Colitis/metabolismo , Sulfato de Dextran/farmacología , Canales Catiónicos TRPV/metabolismo , Animales , Colitis/patología , Colon/efectos de los fármacos , Colon/patología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Enfermedades Inflamatorias del Intestino/metabolismo , Enfermedades Inflamatorias del Intestino/patología , Interleucina-1beta/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Peroxidasa/metabolismo
15.
Neuropeptides ; 44(5): 399-406, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20579732

RESUMEN

Tachykinins encoded by the preprotachykinin A (TAC1) gene such as substance P (SP) and neurokinin A (NKA) are involved in neurogenic inflammatory processes via predominantly neurokinins 1 and 2 (NK1 and NK2) receptor activation, respectively. Endokinins and hemokinins encoded by the TAC4 gene also have remarkable selectivity and potency for the NK1 receptors and might participate in inflammatory cell functions. The aim of the present study was to investigate endotoxin-induced airway inflammation and consequent bronchial hyper-reactivity in TAC1(-/-), NK1(-/-) and also in double knockout (TAC1(-/-)/NK1(-/-)) mice. Sub-acute interstitial lung inflammation was evoked by intranasal Escherichia coli lipopolysaccharide (LPS) in the knockout mice and their wildtype C57BL/6 counterparts 24 h before measurement. Respiratory parameters were measured with unrestrained whole body plethysmography. Bronchoconstriction was induced by inhalation of the muscarinic receptor agonist carbachol and Penh (enhanced pause) correlating with airway resistance was calculated. Lung interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) concentrations were measured with ELISA. Histological evaluation was performed and a composite morphological score was determined. Myeloperoxidase (MPO) activity in the lung was measured with spectrophotometry to quantify the number of infiltrating neutrophils/macrophages. Airway hyper-reactivity was significantly reduced in the TAC1(-/-) as well as the TAC1(-/-)/NK1(-/-) groups. However, LPS-induced histological inflammatory changes (perivascular/peribronchial oedema, neutrophil infiltration and goblet cell hyperplasia), MPO activity and TNF-alpha concentration were markedly diminished only in TAC1(-/-) mice. Interestingly, the concentrations of both cytokines, IL-1beta and TNF-alpha, were significantly greater in the NK1(-/-) group. These data clearly demonstrated on the basis of histology, MPO and cytokine measurements that TAC1 gene-derived tachykinins, SP and NKA, play a significant role in the development of endotoxin-induced murine airway inflammation, but not solely via NK1 receptor activation. However, in inflammatory bronchial hyper-responsiveness other tachykinins, such as hemokinin-1 acting through NK1 receptors also might be involved.


Asunto(s)
Pulmón/metabolismo , Neumonía/metabolismo , Precursores de Proteínas/metabolismo , Receptores de Neuroquinina-1/metabolismo , Taquicininas/metabolismo , Análisis de Varianza , Animales , Bronquios/efectos de los fármacos , Bronquios/metabolismo , Bronquios/patología , Broncoconstricción/efectos de los fármacos , Ensayo de Inmunoadsorción Enzimática , Femenino , Interleucina-1beta/metabolismo , Lipopolisacáridos/farmacología , Pulmón/efectos de los fármacos , Pulmón/patología , Masculino , Ratones , Ratones Noqueados , Peroxidasa/metabolismo , Pletismografía Total , Neumonía/inducido químicamente , Espectrofotometría , Factor de Necrosis Tumoral alfa/metabolismo
16.
Pain ; 141(1-2): 143-50, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19091468

RESUMEN

Pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38) and its receptors have been shown in the spinal dorsal horn, on capsaicin-sensitive sensory neurons and inflammatory cells. The role of PACAP in central pain transmission is controversial, and no data are available on its function in peripheral nociception. Therefore, the aim of the present study was to analyze the effects of locally or systemically administered PACAP-38 on nocifensive behaviors, inflammatory/neuropathic hyperalgesia and afferent firing. Intraplantar PACAP-38 (0.2nmol) injection inhibited carrageenan-evoked inflammatory mechanical allodynia, mild heat injury-induced thermal hyperalgesia, as well as nocifensive behaviors in the early and late phases of the formalin test in rats. However, the above dose did not alter basal mechanical or heat thresholds. In mice, PACAP-38 (0.2nmol/kg s.c.) significantly diminished acetic acid-induced abdominal contractions, but exerted no effect on sciatic nerve ligation-induced neuropathic mechanical hyperalgesia. In contrast, local PACAP-38 injection markedly increased rotation-induced afferent firing in the inflamed rat knee joint clearly demonstrating a peripheral sensitization in this organ. These actions were blocked by VPAC1/VPAC2 receptor antagonist pretreatment, but were not altered by PAC1 receptor antagonism. This paper presents the first data for the peripheral actions of PACAP-38 on nociceptive transmission mediated by VPAC receptors. These effects seem to be divergent depending on the mechanisms of nociceptor activation and the targets of PACAP actions. In acute somatic and visceral inflammatory pain models, PACAP exerts anti-nociceptive, anti-hyperalgesic and anti-allodynic effects. It has no significant peripheral role in traumatic mononeuropathy, but induces mechanical sensitization of knee joint primary afferents.


Asunto(s)
Neurotransmisores/administración & dosificación , Nociceptores/efectos de los fármacos , Dimensión del Dolor/efectos de los fármacos , Umbral del Dolor/efectos de los fármacos , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/administración & dosificación , Potenciales de Acción/efectos de los fármacos , Vías Aferentes/efectos de los fármacos , Vías Aferentes/fisiopatología , Análisis de Varianza , Animales , Carragenina , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Vías de Administración de Medicamentos , Femenino , Hiperalgesia/tratamiento farmacológico , Hiperalgesia/fisiopatología , Inflamación/tratamiento farmacológico , Inflamación/fisiopatología , Articulación de la Rodilla/inervación , Articulación de la Rodilla/fisiopatología , Masculino , Ratones , Neuralgia/tratamiento farmacológico , Neuralgia/fisiopatología , Nociceptores/fisiología , Dolor/clasificación , Dolor/tratamiento farmacológico , Dolor/fisiopatología , Dimensión del Dolor/métodos , Ratas , Ratas Wistar , Factores de Tiempo
17.
J Histochem Cytochem ; 57(12): 1127-37, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19687471

RESUMEN

Somatostatin released from capsaicin-sensitive sensory nerves of the lung during endotoxin-induced murine pneumonitis inhibits inflammation and hyperresponsiveness, presumably via somatostatin receptor subtype 4 (sst(4)). The goal of the present study was to identify sst(4) receptors in mouse and human lungs and to reveal its inflammation-induced alterations with real-time quantitative PCR, Western blot, and immunohistochemistry. In non-inflamed mouse and human lungs, mRNA expression and immunolocalization of sst(4) are very similar. They are present on bronchial epithelial, vascular endothelial, and smooth-muscle cells. The sst(4) receptor protein in the mouse lung significantly increases 24 hr after intranasal endotoxin administration as well as in response to 3 months of whole-body cigarette smoke exposure, owing to the infiltrating sst(4)-positive mononuclear cells and neutrophils. In the chronically inflamed human lung, the large number of activated macrophages markedly elevate sst(4) mRNA levels, although there is no change in acute purulent pneumonia, in which granulocytes accumulate. Despite mouse granulocytes, human neutrophils do not show sst(4) immunopositivity. We provide the first evidence for the expression, localization, and inflammation-induced alterations of sst(4) receptors in murine and human lungs. Inasmuch as tissue distribution of this receptor is highly similar, extrapolation of murine experimental results to human conditions might be possible.


Asunto(s)
Regulación de la Expresión Génica , Pulmón/citología , Pulmón/patología , Receptores de Somatostatina/genética , Receptores de Somatostatina/metabolismo , Animales , Western Blotting , Humanos , Inmunohistoquímica , Inflamación/inducido químicamente , Inflamación/genética , Inflamación/patología , Pulmón/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Especificidad de Órganos , Transporte de Proteínas , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
18.
Arthritis Rheum ; 58(1): 292-301, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18163477

RESUMEN

OBJECTIVE: Along with their classic afferent function (nociception), capsaicin-sensitive transient receptor potential vanilloid 1 (TRPV1) receptor-expressing sensory nerve terminals exert local and systemic efferent activities. Activation of TRPV1 causes sensory neuropeptide release, which modulates the inflammation process. The aim of the present study was to examine the role of this modulatory role of TRPV1 receptor and that of calcitonin gene-related peptide (CGRP) in bleomycin-induced scleroderma, using transgenic mice. METHODS: Cutaneous sclerosis was induced with daily subcutaneous injections of bleomycin for 30 days. Control groups were treated with phosphate buffered saline (PBS). TRPV1 receptor gene-deficient (TRPV1(-/-)) mice and CGRP-knockout (CGRP(-/-)) mice and their wild-type (WT) counterparts were investigated. A composite sclerosis score was calculated on the basis of thickening, leukocyte infiltration, and the amount/orientation of collagen bundles. Dermal thickness and the number of alpha-smooth muscle actin (alpha-SMA)-positive cells were also determined. The quantity of the collagen-specific amino acid hydroxyproline was measured by spectrophotometry. RESULTS: Bleomycin treatment induced marked cutaneous thickening and fibrosis compared with that observed in control mice treated with PBS. The composite sclerosis score was 18% higher, dermal thickness was 19% higher, the number of alpha-SMA-positive cells was 47% higher, and the amount of hydroxyproline was 57% higher in TRPV1(-/-) mice than in their WT counterparts. Similarly, the composite sclerosis score was 47% higher, dermal thickness was 29% higher, the number of alpha-SMA-positive cells was 76% higher, and the amount of hydroxyproline was 30% higher in CGRP(-/-) mice than in the respective WT groups. CONCLUSION: These results suggest that activation of the TRPV1 receptor by mediators of inflammation induces sensory neuropeptide release, which might exert protective action against fibrosis. We confirmed the protective role of CGRP in the development of cutaneous sclerosis.


Asunto(s)
Péptido Relacionado con Gen de Calcitonina/genética , Neuronas Aferentes/fisiología , Esclerodermia Sistémica/fisiopatología , Canales Catiónicos TRPV/genética , Animales , Antibióticos Antineoplásicos , Bleomicina , Colágeno Tipo I/genética , Dermis/patología , Dermis/fisiopatología , Modelos Animales de Enfermedad , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Esclerodermia Sistémica/inducido químicamente , Esclerodermia Sistémica/patología
19.
Am J Physiol Lung Cell Mol Physiol ; 292(5): L1173-81, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17237150

RESUMEN

Airways are densely innervated by capsaicin-sensitive sensory neurons expressing transient receptor potential vanilloid 1 (TRPV1) receptors/ion channels, which play an important regulatory role in inflammatory processes via the release of sensory neuropeptides. The aim of the present study was to investigate the role of TRPV1 receptors in endotoxin-induced airway inflammation and consequent bronchial hyperreactivity with functional, morphological, and biochemical techniques using receptor gene-deficient mice. Inflammation was evoked by intranasal administration of Escherichia coli lipopolysaccharide (60 microl, 167 microg/ml) in TRPV1 knockout (TRPV1(-/-)) mice and their wild-type counterparts (TRPV1(+/+)) 24 h before measurement. Airway reactivity was assessed by unrestrained whole body plethysmography, and its quantitative indicator, enhanced pause (Penh), was calculated after inhalation of the bronchoconstrictor carbachol. Histological examination and spectrophotometric myeloperoxidase measurement was performed from the lung. Somatostatin concentration was measured in the lung and plasma with radioimmunoassay. Bronchial hyperreactivity, histological lesions (perivascular/peribronchial edema, neutrophil/macrophage infiltration, goblet cell hyperplasia), and myeloperoxidase activity were significantly greater in TRPV(-/-) mice. Inflammation markedly elevated lung and plasma somatostatin concentrations in TRPV1(+/+) but not TRPV1(-/-) animals. In TRPV1(-/-) mice, exogenous administration of somatostatin-14 (4 x 100 microg/kg ip) diminished inflammation and hyperreactivity. Furthermore, in wild-type mice, antagonizing somatostatin receptors by cyclo-somatostatin (4 x 250 microg/kg ip) increased these parameters. This study provides the first evidence for a novel counterregulatory mechanism during endotoxin-induced airway inflammation, which is mediated by somatostatin released from sensory nerve terminals in response to activation of TRPV1 receptors of the lung. It reaches the systemic circulation and inhibits inflammation and consequent bronchial hyperreactivity.


Asunto(s)
Hiperreactividad Bronquial/fisiopatología , Endotoxinas/toxicidad , Inflamación/fisiopatología , Canales Catiónicos TRPV/deficiencia , Canales Catiónicos TRPV/fisiología , Animales , Hiperreactividad Bronquial/genética , Hiperreactividad Bronquial/patología , Carbacol/farmacología , Inflamación/genética , Inflamación/patología , Lipopolisacáridos/toxicidad , Ratones , Ratones Noqueados , Somatostatina/farmacología , Canales Catiónicos TRPV/genética
20.
J Pharmacol Exp Ther ; 314(1): 111-9, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15831443

RESUMEN

The transient receptor potential vanilloid 1 (TRPV1) receptor is a nonselective cation channel localized on a subset of primary sensory neurons and can be activated by a wide range of stimuli. The present study investigated the role of this receptor in chronic arthritis evoked by complete Freund's adjuvant (CFA) using TRPV1 receptor gene-deleted (TRPV1-/-) mice and wild-type counterparts (TRPV1+/+). In TRPV1+/+ mice, CFA injected intraplantarly into the left hindpaw and the root of the tail induced swelling of the injected and contralateral paws up to 130 and 28%, respectively, measured by plethysmometry throughout 18 days. Mechanonociceptive threshold measured with dynamic plantar aesthesiometry was decreased by 50 and 18% on the injected and contralateral paws, respectively. Histological examination and scoring of the tibiotarsal joints revealed marked arthritic changes in wild-type mice. In TRPV1-/- animals edema, histological score and mechanical allodynia were significantly smaller. Daily treatment with the lipoxygenase inhibitor nordihydroguaretic acid (NDGA), the cyclooxygenase inhibitor indomethacin, the bradykinin B2 receptor antagonist HOE-140 [D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thyenyl)-L-alanyl-L-seryl-D-1,2,2,4-tetrahydro-3-isoquinolinecarbonyl-L-(2a,3b,7ab)-octahydro-1H-indole-2-carbonyl-L-arginine], or the B1 receptor antagonist desArgHOE-140 [D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thyenyl)-L-alanyl-L-seryl-D-1,2,2,4-tetrahydro-3-isoquinolinecarbonyl-L-(2a,3b,7ab)-octahydro-1H-indole-2-carbonyl] was performed to reveal what mediators might activate TRPV1. NDGA significantly inhibited edema, hyperalgesia, and arthritis score in TRPV1+/+, but not in TRPV1-/- mice. The effect of indomethacin was markedly smaller in knockouts. In TRPV1+/+ animals, HOE-140, but not desArgHOE-140, inhibited arthritis, whereas in TRPV1-/- mice, HOE-140 produced limited effect. Thus, whereas bradykinin and lipoxygenase products seem to act exclusively via TRPV1 activation, prostanoids do not, or at least only partially, to enhance murine experimental arthritis and related hyperalgesia.


Asunto(s)
Artritis Experimental/genética , Artritis Experimental/fisiopatología , Receptores de Droga/genética , Receptores de Droga/fisiología , Animales , Artritis Experimental/patología , Bradiquinina/análogos & derivados , Bradiquinina/farmacología , Bradiquinina/fisiología , Inhibidores de la Ciclooxigenasa/farmacología , Edema/inducido químicamente , Edema/patología , Inhibidores Enzimáticos/farmacología , Hiperalgesia/genética , Hiperalgesia/fisiopatología , Indometacina/farmacología , Articulaciones/patología , Lipooxigenasa/metabolismo , Inhibidores de la Lipooxigenasa/farmacología , Masculino , Mecanorreceptores/efectos de los fármacos , Ratones , Ratones Noqueados , Umbral del Dolor/efectos de los fármacos , Prostaglandina-Endoperóxido Sintasas/metabolismo , Receptores de Droga/antagonistas & inhibidores
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA